Skip to main content
OpenTrials
Completed

NCT Number: NCT07455474

Clinical Research Study of the Benefits of BREG Polar Care Wave to Reduce Opioid Use by Patients Having Undergone Arthroscopic Rotator Cuff Repair Shoulder Surgery

The goal of this clinical trial is to compare effect of cold compression to standard of care in patients undergoing rotator cuff repair. The main question[s] it aims to answer are:

* whether opioid use is decreased in the experimental cold compression group * whether patient reported outcomes and pain scores are reduced in the experimental cold compression group Participants will be randomized to standard postoperative care versus standard postoperative care with use of cold compression therapy Researchers will compare control and experimental cold compression groups to see if there are differences between groups

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mammoth Hospital, Mammoth Lakes, California, United States

Loading trial locations.

About this study

The primary objective of this study is to determine whether patients, who have undergone arthroscopic rotator cuff repair surgery and who use the Polar Care Wave, use fewer opioids for a shorter duration post-operatively relative to the standard of care. Therefore, all patients enrolled in the study will be prescribed opioids for pain control after surgery. These medications will be taken at the discretion of each patient but not more than the dose recommended by the physician.

The secondary objectives of this study are to determine whether patients who have undergone arthroscopic rotator cuff repair surgery and who use the Polar Care Wave:

  • experience lower pain during the 30-day post-operative period relative to the standard of care.
  • experience improved quality of sleep during the 30-day post-operative period relative to the standard of care assessed via the Pittsburg Sleep Quality Index (Appendix B).
  • experience improved post-surgical physical therapy outcomes measured by range of motion (ROM) relative to the standard of care.

We hypothesize that patients using the Polar Care Wave will report less frequent use and lower doses of opioid pain medications, a lower degree of pain, and improved sleep quality during the 30-day post-operative recovery period compared to patients recovering with the current standard of care (the control). We also hypothesize that these patients will have better ROM measures at 6 weeks post-operative compared to the control.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • • Patients scheduled for arthroscopic rotator cuff surgical repair between the dates of July 17, 2023, and November 30, 2023
  • Adult males and females ages 18 to 70
  • No prior experience using the Breg Polar Care Wave device
  • No adverse underlying medical conditions or comorbidities that may enhance pain, require drugs that interact with opioids, or otherwise confound the results
  • Ownership of or daily access to a smart phone or internet-connected computer

Exclusion criteria

  • • Patients scheduled for arthroscopic rotator cuff surgical repair outside the dates of July 17, 2023, and November 30, 2023
  • Adults aged 71 and above
  • Children below the age of 18
  • Other medical conditions or concomitant medication use that are known to negatively impact the outcome of rotator cuff repair

o These include diabetes, current smoker, workers compensation claim, history of prior surgery on same shoulder, chronic pain, and pre-operative opioid use. Exclusion of this population is necessary in order to limit the introduction of confounding factors that could affect opioid usage independent of the Polar Care Wave.

  • Concurrent participation in other studies
  • Prior experience using the Breg Polar Care Wave device
  • Do not have daily access to an internet-connected device to provide study data

Treatment and study plan

Breg Polar Care Wave Cold Compression Device

Device

cold compression sleeve

Primary outcomes

  1. postoperative opioid consumption using milligram morphine equivalents

    Time frame: 6 weeks

    opioid consumption conversion of opioid consumption to MMEQ

Secondary outcomes

  1. VAS

    Time frame: 6 weeks

    VAS pain scores

  2. sleep quality

    Time frame: 6 weeks

    pittsburgh sleep quality index

Sponsors and collaborators

Lead sponsor

University of Nevada, Reno

Other

Collaborators

  • Mammoth Orthopedic Institute
  • Taos Orthopedic Institute

Registry information

Official study title

Clinical Research Study of the Benefits of Cold Compression to Reduce Opioid Use by Patients Having Undergone Arthroscopic Rotator Cuff Repair Shoulder Surgery

Acronym: CCROUT

Important dates

Study start
2023
Primary completion
2025
Study completion
2026
First posted
Mar 6, 2026
Registry last updated
Mar 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.